HIF-1α’s role in MS is only partially known; for instance, histopathological studies have found, in active lesions with distal dying-back oligodendrogliopathy, the pronounced expression of HIF-1α, suggesting that hypoxic tissue damage plays a role in specific demyelinating patterns. This evidence concerns the gene HIF1A and myeloid sarcoma.